Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain implant offers new hope for hard-to-treat seizure disorder

NCT ID NCT05339126

First seen Jan 12, 2026 · Last updated May 21, 2026 · Updated 17 times

Summary

This study tests a brain-responsive neurostimulation system in 24 people aged 12 and older with Lennox-Gastaut syndrome whose seizures are not controlled by medication. The device is implanted in the brain and delivers electrical stimulation when it detects seizure activity, aiming to reduce drop seizures. The goal is to gather safety and effectiveness data to plan a larger study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Emory University

    Atlanta, Georgia, 30322, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Mount Sinai Hospital

    New York, New York, 10029, United States

  • NYU Langone Medical Center

    New York, New York, 10016, United States

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35294, United States

  • University of California, San Francisco

    San Francisco, California, 94143, United States

Conditions

Explore the condition pages connected to this study.